Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treating systemic lupus erythematosus in the 21st century: new drugs and new perspectives on old drugs
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume 59, Issue Supplement_5, Pages v69-v81
Publisher
Oxford University Press (OUP)
Online
2020-06-20
DOI
10.1093/rheumatology/keaa403
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of JAK 1/2 inhibition in the treatment of diffuse non-scarring alopecia due to systemic lupus erythematosus
- (2020) Keisuke Maeshima et al. ANNALS OF THE RHEUMATIC DISEASES
- Inhibition of mTOR suppresses IFNα production and the STING pathway in monocytes from systemic lupus erythematosus patients
- (2020) Goh Murayama et al. RHEUMATOLOGY
- Seventy years after Hench’s Nobel prize: revisiting the use of glucocorticoids in systemic lupus erythematosus
- (2020) Guillermo Ruiz-Irastorza et al. LUPUS
- Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER study
- (2019) Marc Scherlinger et al. ANNALS OF THE RHEUMATIC DISEASES
- Organ damage in patients treated with belimumab versus standard of care: a propensity score-matched comparative analysis
- (2019) Murray B Urowitz et al. ANNALS OF THE RHEUMATIC DISEASES
- Safety and efficacy of belimumab plus standard therapy for up to 13 years in patients with systemic lupus erythematosus
- (2019) Daniel J Wallace et al. Arthritis & Rheumatology
- Evolution of retinal changes measured by optical coherence tomography in the assessment of hydroxychloroquine ocular safety in patients with systemic lupus erythematosus
- (2019) D Martín-Iglesias et al. LUPUS
- Lupus Low Disease Activity State (LLDAS) discriminates responders in the BLISS-52 and BLISS-76 phase III trials of belimumab in systemic lupus erythematosus
- (2019) Shereen Oon et al. ANNALS OF THE RHEUMATIC DISEASES
- 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
- (2019) Antonis Fanouriakis et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab as maintenance treatment for systemic Lupus Erythematosus: a multicentre observational study of 147 patients
- (2019) Matthias A. Cassia et al. Arthritis & Rheumatology
- Prolonged remission in SLE is possible by using reduced doses of prednisone: An observational study from the Lupus-Cruces and Lupus-Bordeaux inception cohorts
- (2019) Guillermo Ruiz-Irastorza et al. AUTOIMMUNITY REVIEWS
- Factors predictive of serious infections over time in systemic lupus erythematosus patients: data from a multi-ethnic, multi-national, Latin American lupus cohort
- (2019) V R Pimentel-Quiroz et al. LUPUS
- Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus
- (2019) Ioannis Parodis et al. RHEUMATOLOGY
- Long-term safety and limited organ damage in patients with systemic lupus erythematosus treated with belimumab: a Phase III study extension
- (2019) Ronald F van Vollenhoven et al. RHEUMATOLOGY
- Effectiveness and safety of belimumab in patients with systemic lupus erythematosus in a real-world setting
- (2019) C Anjo et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial
- (2019) Jing He et al. ANNALS OF THE RHEUMATIC DISEASES
- Trial of Anifrolumab in Active Systemic Lupus Erythematosus
- (2019) Eric F. Morand et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults
- (2018) Alexandra Serris et al. AMERICAN JOURNAL OF HEMATOLOGY
- A pivotal phase III, randomised, placebo-controlled study of belimumab in patients with systemic lupus erythematosus located in China, Japan and South Korea
- (2018) Fengchun Zhang et al. ANNALS OF THE RHEUMATIC DISEASES
- Glucocorticoids and antimalarials in systemic lupus erythematosus
- (2018) Amaia Ugarte et al. CURRENT OPINION IN RHEUMATOLOGY
- Smoking reduces the efficacy of belimumab in mucocutaneous lupus
- (2018) Ioannis Parodis et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study
- (2018) Luca Iaccarino et al. JOURNAL OF AUTOIMMUNITY
- Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis
- (2018) Camille Garnier et al. JOURNAL OF RHEUMATOLOGY
- Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
- (2018) Daniel J Wallace et al. LANCET
- Combined mepacrine–hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity
- (2018) A Ugarte et al. LUPUS
- Ofatumumab for B cell depletion in patients with systemic lupus erythematosus who are allergic to rituximab
- (2018) Sherry Masoud et al. RHEUMATOLOGY
- Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort
- (2018) Jayne Little et al. RHEUMATOLOGY
- Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study
- (2018) Antonis Fanouriakis et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Restrictive Use of Oral Glucocorticoids in Systemic Lupus Erythematosus and Prevention of Damage Without Worsening Long-Term Disease Control: An Observational Study
- (2018) Ioana Ruiz-Arruza et al. ARTHRITIS CARE & RESEARCH
- Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus
- (2018) A. Doria et al. Arthritis & Rheumatology
- Long-Term Safety and Efficacy of Belimumab in Patients With Systemic Lupus Erythematosus
- (2018) Richard A. Furie et al. Arthritis & Rheumatology
- A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self-Administered Questionnaires
- (2018) Nathalie Costedoat-Chalumeau et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis
- (2018) Brad H. Rovin et al. KIDNEY INTERNATIONAL
- Infections in newly diagnosed Spanish patients with systemic lupus erythematosus: data from the RELES cohort
- (2018) C González-Echavarri et al. LUPUS
- Long-term impact of belimumab on health-related quality of life and fatigue in patients with systemic lupus erythematosus: 6 years of treatment
- (2018) Vibeke Strand et al. ARTHRITIS CARE & RESEARCH
- Assessment of Response to B-Cell Depletion Using Rituximab in Cutaneous Lupus Erythematosus
- (2018) Rita Quelhas da Costa et al. JAMA Dermatology
- JAK inhibitor ruxolitinib inhibits the expression of cytokines characteristic of cutaneous lupus erythematosus
- (2017) Anna Sophie Klaeschen et al. EXPERIMENTAL DERMATOLOGY
- BAFF Induces Tertiary Lymphoid Structures and Positions T Cells within the Glomeruli during Lupus Nephritis
- (2017) SunAh Kang et al. JOURNAL OF IMMUNOLOGY
- More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus
- (2017) Rattapol Pakchotanon et al. JOURNAL OF RHEUMATOLOGY
- Multitarget Therapy for Maintenance Treatment of Lupus Nephritis
- (2017) Haitao Zhang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Antimalarial-induced cardiomyopathy: a systematic review of the literature
- (2017) K Tselios et al. LUPUS
- Effect of immunosuppressive therapies on survival of systemic lupus erythematosus: a propensity score analysis of a longitudinal cohort
- (2017) C C Mok et al. LUPUS
- Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register
- (2017) Eoghan M McCarthy et al. RHEUMATOLOGY
- The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults
- (2017) Caroline Gordon et al. RHEUMATOLOGY
- Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus
- (2017) Íñigo Rúa-Figueroa et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Brief Report: The Euro-Lupus Low-Dose Intravenous Cyclophosphamide Regimen Does Not Impact the Ovarian Reserve, as Measured by Serum Levels of Anti-Müllerian Hormone
- (2017) Farah Tamirou et al. Arthritis & Rheumatology
- Effect of Corticosteroids and Cyclophosphamide on Sex Hormone Profiles in Male Patients With Systemic Lupus Erythematosus or Systemic Sclerosis
- (2017) Laurent Arnaud et al. Arthritis & Rheumatology
- Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study
- (2017) William Stohl et al. Arthritis & Rheumatology
- Effects of chronic exposure of hydroxychloroquine/ chloroquine on the risk of cancer, metastasis, and death: a population-based cohort study on patients with connective tissue diseases
- (2017) L Fardet et al. Clinical Epidemiology
- EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome
- (2016) L Andreoli et al. ANNALS OF THE RHEUMATIC DISEASES
- Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study
- (2016) K. Tselios et al. JOURNAL OF RHEUMATOLOGY
- Long-term organ damage accrual and safety in patients with SLE treated with belimumab plus standard of care
- (2016) I N Bruce et al. LUPUS
- Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)
- (2016) Michael F. Marmor et al. OPHTHALMOLOGY
- Cumulative Corticosteroid Dose Over Fifty-Two Weeks in Patients With Systemic Lupus Erythematosus: Pooled Analyses From the Phase III Belimumab Trials
- (2016) Ronald F. van Vollenhoven et al. Arthritis & Rheumatology
- Multitarget Therapy for Induction Treatment of Lupus Nephritis
- (2015) Zhihong Liu et al. ANNALS OF INTERNAL MEDICINE
- The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus
- (2015) Tobias Alexander et al. ANNALS OF THE RHEUMATIC DISEASES
- Comparison of high versus low–medium prednisone doses for the treatment of systemic lupus erythematosus patients with high activity at diagnosis
- (2015) Ioana Ruiz-Arruza et al. AUTOIMMUNITY REVIEWS
- Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-centre study
- (2015) A Fanouriakis et al. LUPUS
- Unraveling the functions of the membrane-bound glucocorticoid receptors: first clues on origin and functional activity
- (2014) Cindy Strehl et al. Annals of the New York Academy of Sciences
- Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up
- (2014) Chi Chiu Mok et al. ANNALS OF THE RHEUMATIC DISEASES
- Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
- (2014) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Time to Recovery from Proteinuria in Patients with Lupus Nephritis Receiving Standard Treatment
- (2014) Z. Touma et al. JOURNAL OF RHEUMATOLOGY
- Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy
- (2014) R Sakthiswary et al. LUPUS
- Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus
- (2014) I. Ruiz-Arruza et al. RHEUMATOLOGY
- Long-term data on tacrolimus treatment in lupus nephritis
- (2014) Desmond Y. H. Yap et al. RHEUMATOLOGY
- Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: A systematic review
- (2014) Tatiana Cobo-Ibáñez et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- The Risk of Toxic Retinopathy in Patients on Long-term Hydroxychloroquine Therapy
- (2014) Ronald B. Melles et al. JAMA Ophthalmology
- Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids
- (2013) Marie B Condon et al. ANNALS OF THE RHEUMATIC DISEASES
- Prednisone in lupus nephritis: How much is enough?
- (2013) Guillermo Ruiz-Irastorza et al. AUTOIMMUNITY REVIEWS
- Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
- (2012) Nathalie Costedoat-Chalumeau et al. ANNALS OF THE RHEUMATIC DISEASES
- Belimumab in the treatment of systemic lupus erythematosus: high disease activity predictors of response
- (2012) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: combined results from two phase III trials
- (2012) Susan Manzi et al. ANNALS OF THE RHEUMATIC DISEASES
- Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
- (2012) George K Bertsias et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Renal Outcome in Patients with Lupus Nephritis Using a Steroid-free Regimen of Monthly Intravenous Cyclophosphamide: A Prospective Observational Study
- (2012) R. FISCHER-BETZ et al. JOURNAL OF RHEUMATOLOGY
- Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE
- (2012) MA Dooley et al. LUPUS
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis
- (2012) Bevra H. Hahn et al. ARTHRITIS CARE & RESEARCH
- Efficacy and safety of enteric-coated mycophenolate sodium in combination with two glucocorticoid regimens for the treatment of active lupus nephritis
- (2011) M Zeher et al. LUPUS
- EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs
- (2010) G. K. Bertsias et al. ANNALS OF THE RHEUMATIC DISEASES
- Antimalarial treatment may have a time-dependent effect on lupus survival: Data from a multinational Latin American inception cohort
- (2010) Samuel K. Shinjo et al. ARTHRITIS AND RHEUMATISM
- The BILAG multi-centre open randomized controlled trial comparing ciclosporin vs azathioprine in patients with severe SLE
- (2010) B. Griffiths et al. RHEUMATOLOGY
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Randomized, Controlled Trial of Prednisone, Cyclophosphamide, and Cyclosporine in Lupus Membranous Nephropathy
- (2009) H. A. Austin et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Predictors of major infections in systemic lupus erythematosus
- (2009) Guillermo Ruiz-Irastorza et al. ARTHRITIS RESEARCH & THERAPY
- Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
- (2008) G Ruiz-Irastorza et al. ANNALS OF THE RHEUMATIC DISEASES
- Steroid-sparing effects of methotrexate in systemic lupus erythematosus: A double-blind, randomized, placebo-controlled trial
- (2008) Paul R. Fortin et al. ARTHRITIS AND RHEUMATISM
- Hydroxychloroquine: the cornerstone of lupus therapy
- (2008) G Ruiz-Irastorza et al. LUPUS
- Genomic and nongenomic effects of glucocorticoids
- (2008) Cindy Stahn et al. Nature clinical practice. Rheumatology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search